A Harvard- and Stanford-trained Cardiac Surgeon who also received a D.Phil from Oxford University as a Churchill Scholar on the application of new technology in clinical medicine. During his Post-Doctorate Fellowship at Harvard Medical School, he developed new diagnostic tests for organ rejection. Funded by the NIH, Howard Hughes Institute, and others, he has received over ten research awards and multiple patents for medical implants.

A Harvard- and Boston University-trained Scientist, formerly Principal Scientist for Computer Vision at Charles River Analytics. He was responsible for multiple Pentagon-sponsored video analysis programs, as well as for image analyses used by a NASA rover currently on Mars. He is an experienced team leader in the management and development of computer vision projects.

She was Director of the Office of Device Evaluation (ODE) at the FDA, where she was responsible for the review and approval of all medical devices in the U.S. She personally wrote the FDA regulations for medical software, and was recruited by Microsoft to head the Regulatory Affairs Office. She is taking the lead in guiding our software through the FDA approval process.

Associate Professor of Dermatology at Harvard Medical School, Director of the Melanoma and Pigmented Lesion Center at the Massachusetts General Hospital, Boston, MA. He provides continuous feedback and evaluation of the project and will co-lead the clinical efforts to introduce the Lubax device to Dermatologists.

Former co-founder HiSoft USA (Envisage Solutions), IPO Nasdaq 2010, 20 years of experience in technology, consulting and business development.